Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOCL
11201
CALL
EDAP TMS S.A.
FOCL
$178M
| $112K | ﹤0.01% |
16,500
-11,600
| -41% | -$80.4K |
|
11202
US Global Investors
GROW
$39.4M
| $112K | ﹤0.01% |
25,490
+4,475
| +21% | +$21.8K |
|
11203
CALL
Hudbay
HBM
$11.9B
| $112K | ﹤0.01% |
27,500
-7,700
| -22% | -$46K |
|
11204
Lightpath Technologies
LPTH
$953M
| $112K | ﹤0.01% |
90,446
+38,316
| +74% | +$60.1K |
|
11205
PUT
Liquidia Corp
LQDA
$6.66B
| $112K | ﹤0.01% |
+25,600
| New | +$132K |
|
11206
PUT
Spok Holdings
SPOK
$229M
| $112K | ﹤0.01% |
17,800
-10,200
| -36% | -$74.2K |
|
11207
PUT
Kartoon Studios
TOON
$37.4M
| $112K | ﹤0.01% |
14,820
-10,210
| -41% | -$78.1K |
|
11208
PUT
Vanda Pharmaceuticals
VNDA
$316M
| $112K | ﹤0.01% |
10,300
-1,300
| -11% | -$13.5K |
|
11209
PUT
Full Truck Alliance
YMM
$9.14B
| $112K | ﹤0.01% |
12,400
-19,300
| -61% | -$131K |
|
|
BKEP
11210
PUT
DELISTED
Blueknight Energy Partners L.P.
BKEP
| $112K | ﹤0.01% |
24,700
-54,600
| -69% | -$232K |
|
11211
PUT
Arbe Robotics
ARBE
$97.8M
| $111K | ﹤0.01% |
+20,100
| New | +$137K |
|
|
MRIN
11212
CALL
DELISTED
Marin Software
MRIN
| $111K | ﹤0.01% |
11,233
-7,617
| -40% | -$97.3K |
|
|
PGRWU
11213
DELISTED
Progress Acquisition Corp. Units
PGRWU
| $111K | ﹤0.01% |
11,235
-1,898
| -14% | -$18.8K |
|
|
UPH
11214
CALL
DELISTED
UpHealth, Inc.
UPH
| $111K | ﹤0.01% |
18,770
+2,300
| +14% | +$17.9K |
|
|
AMPE
11215
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $111K | ﹤0.01% |
2,210
+2,137
| +2,927% | +$159K |
|
|
CFRX
11216
PUT
DELISTED
ContraFect Corporation
CFRX
| $111K | ﹤0.01% |
+453
| New | +$128K |
|
|
DOYU
11217
CALL
DouYu International Holdings
DOYU
$142M
| $110K | ﹤0.01% |
9,190
+3,030
| +49% | +$46.4K |
|
11218
Gaotu Techedu
GOTU
$401M
| $110K | ﹤0.01% |
56,246
+22,465
| +67% | +$36K |
|
11219
HF Foods Group
HFFG
$99.2M
| $110K | ﹤0.01% |
21,039
-54,330
| -72% | -$304K |
|
|
REVG
11220
DELISTED
REV Group
REVG
| $110K | ﹤0.01% |
+10,124
| New | +$120K |
|
|
ORKA
11221
Oruka Therapeutics
ORKA
$7.35B
| $110K | ﹤0.01% |
3,669
-809
| -18% | -$22.9K |
|
|
VVNT
11222
CALL
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $110K | ﹤0.01% |
31,500
-4,900
| -13% | -$26.1K |
|
11223
CALL
Acacia Research
ACTG
$448M
| $109K | ﹤0.01% |
21,700
+3,300
| +18% | +$15.1K |
|
11224
Cyngn
CYN
$16M
| $109K | ﹤0.01% |
+7
| New | +$203K |
|
11225
CALL
SurgePays
SURG
$7.08M
| $109K | ﹤0.01% |
+22,600
| New | +$95.3K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.